These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27966701)

  • 1. Synthesis and cellular activity of stereochemically-pure 2'-O-(2-methoxyethyl)-phosphorothioate oligonucleotides.
    Li M; Lightfoot HL; Halloy F; Malinowska AL; Berk C; Behera A; Schümperli D; Hall J
    Chem Commun (Camb); 2017 Jan; 53(3):541-544. PubMed ID: 27966701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages.
    Wan WB; Migawa MT; Vasquez G; Murray HM; Nichols JG; Gaus H; Berdeja A; Lee S; Hart CE; Lima WF; Swayze EE; Seth PP
    Nucleic Acids Res; 2014 Dec; 42(22):13456-68. PubMed ID: 25398895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.
    Iwamoto N; Butler DCD; Svrzikapa N; Mohapatra S; Zlatev I; Sah DWY; Meena ; Standley SM; Lu G; Apponi LH; Frank-Kamenetsky M; Zhang JJ; Vargeese C; Verdine GL
    Nat Biotechnol; 2017 Sep; 35(9):845-851. PubMed ID: 28829437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereocontrolled synthesis of oligoribonucleoside phosphorothioates by an oxazaphospholidine approach.
    Oka N; Kondo T; Fujiwara S; Maizuru Y; Wada T
    Org Lett; 2009 Feb; 11(4):967-70. PubMed ID: 19159256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-1,3-Glucan/antisense oligonucleotide complex stabilized with phosphorothioation and its gene suppression.
    Mochizuki S; Sakurai K
    Bioorg Chem; 2010 Dec; 38(6):260-4. PubMed ID: 20673953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.
    Østergaard ME; De Hoyos CL; Wan WB; Shen W; Low A; Berdeja A; Vasquez G; Murray S; Migawa MT; Liang XH; Swayze EE; Crooke ST; Seth PP
    Nucleic Acids Res; 2020 Feb; 48(4):1691-1700. PubMed ID: 31980820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-
    Honcharenko D; Rocha CSJ; Lundin KE; Maity J; Milton S; Tedebark U; Murtola M; Honcharenko M; Slaitas A; Smith CIE; Zain R; Strömberg R
    Nucleic Acid Ther; 2022 Jun; 32(3):221-233. PubMed ID: 35238623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.
    Kandasamy P; McClorey G; Shimizu M; Kothari N; Alam R; Iwamoto N; Kumarasamy J; Bommineni GR; Bezigian A; Chivatakarn O; Butler DCD; Byrne M; Chwalenia K; Davies KE; Desai J; Shelke JD; Durbin AF; Ellerington R; Edwards B; Godfrey J; Hoss A; Liu F; Longo K; Lu G; Marappan S; Oieni J; Paik IH; Estabrook EP; Shivalila C; Tischbein M; Kawamoto T; Rinaldi C; Rajão-Saraiva J; Tripathi S; Yang H; Yin Y; Zhao X; Zhou C; Zhang J; Apponi L; Wood MJA; Vargeese C
    Nucleic Acids Res; 2022 Jun; 50(10):5443-5466. PubMed ID: 35061895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
    Shen L; Siwkowski A; Wancewicz EV; Lesnik E; Butler M; Witchell D; Vasquez G; Ross B; Acevedo O; Inamati G; Sasmor H; Manoharan M; Monia BP
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):129-42. PubMed ID: 12954113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
    Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
    Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
    Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
    Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-
    Zhang L; Liang XH; De Hoyos CL; Migawa M; Nichols JG; Freestone G; Tian J; Seth PP; Crooke ST
    Nucleic Acid Ther; 2022 Oct; 32(5):401-411. PubMed ID: 35861704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal stability and conformation of antiparallel duplexes formed by P-stereodefined phosphorothioate DNA/LNA chimeric oligomers with DNA and RNA matrices.
    Jastrzębska K; Maciaszek A; Dolot R; Bujacz G; Guga P
    Org Biomol Chem; 2015 Oct; 13(39):10032-40. PubMed ID: 26293357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats.
    Geary RS; Khatsenko O; Bunker K; Crooke R; Moore M; Burckin T; Truong L; Sasmor H; Levin AA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):898-904. PubMed ID: 11181922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Versatile and Convenient Synthesis of
    Stulz R; Meuller J; Baždarević D; Wennberg Huldt C; Strömberg R; Andersson S; Dahlén A
    Chembiochem; 2018 Oct; 19(19):2114-2119. PubMed ID: 30062829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of chimeric oligonucleotides containing phosphodiester, phosphorothioate, and phosphoramidate linkages.
    Maier MA; Guzaev AP; Manoharan M
    Org Lett; 2000 Jun; 2(13):1819-22. PubMed ID: 10891166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO-PS Backbone for Splice-Switching Applications.
    Le BT; Chen S; Veedu RN
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide repress telomerase activity via manipulating alternative splicing or translation.
    Zhou J; Li T; Geng X; Sui L; Wang F
    Biochem Biophys Res Commun; 2021 Dec; 582():118-124. PubMed ID: 34710826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.